Skip to main content
SpringerLink
Log in

Cardiovascular Problems in the Elderly

  • Chapter
  • First Online:
Evidence-Based Cardiology Consult

Abstract

Aging is associated with diffuse changes throughout the cardiovascular system that significantly impact the clinical features, management, and prognosis of older patients with cardiovascular disease. As a result of these changes, cardiovascular reserve capacity declines progressively with age, while the incidence and prevalence of cardiovascular diseases increase with age in both men and women. In addition, age-related changes predispose older individuals to specific cardiovascular disorders, including systolic hypertension, non-ST-segment elevation myocardial infarction, heart failure with preserved ejection fraction, aortic stenosis, syncope, atrial fibrillation, and sinoatrial dysfunction. While the management of older patients with cardiovascular disease is generally similar to that in younger patients, prevalent comorbid conditions, quality of life considerations, and personal preferences become increasingly important for ensuring patient-centered care in older adults. This chapter provides an overview of clinically relevant effects of cardiovascular aging and discusses the pathophysiology, diagnosis, and management of cardiovascular conditions commonly encountered in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.

    Article  PubMed  Google Scholar 

  2. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National hospital discharge survey: 2007 summary. National health statistics reports; no 29. Hyattsville: National Center for Health Statistics; 2010.

    Google Scholar 

  3. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–46.

    Article  PubMed  Google Scholar 

  4. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54.

    Article  PubMed  Google Scholar 

  5. Chobanian AV. Clinical practice. Isolated systolic hypertension in the elderly. N Engl J Med. 2007;357:789–96.

    Article  PubMed  CAS  Google Scholar 

  6. Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation. 2007;115:1921–32.

    Article  PubMed  Google Scholar 

  7. Monahan KD. Effect of aging on baroreflex function in humans. Am J Physiol. 2007;293:R3–12.

    CAS  Google Scholar 

  8. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Am Coll Cardiol. 2011;57:2037–114.

    Article  PubMed  Google Scholar 

  9. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    Article  PubMed  CAS  Google Scholar 

  10. Ghandehari H, Kamal-Bahl S, Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J. 2008;156:112–9.

    Article  PubMed  CAS  Google Scholar 

  11. Kannel WB, Wilson PWF. An update on coronary risk factors. Med Clin North Am. 1995;79:951–71.

    PubMed  CAS  Google Scholar 

  12. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22.

    Article  Google Scholar 

  13. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–30.

    Article  PubMed  CAS  Google Scholar 

  14. Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Ann Intern Med. 2010;152:488–96.

    Article  PubMed  Google Scholar 

  15. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RG. Total cholesterol and risk of mortality in the oldest old. Lancet. 1997;350:1119–23.

    Article  PubMed  CAS  Google Scholar 

  16. Newson RS, Felix JF, Heeringa J, Hofman A, Witterman JC, Tiemeier H. Association between serum cholesterol and noncardiovascular mortality in older age. J Am Geriatr Soc. 2011;59:1779–85.

    Article  PubMed  Google Scholar 

  17. Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29:800–11.

    Article  PubMed  CAS  Google Scholar 

  18. American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care. 2011;34 Suppl 1:S11–61.

    Article  Google Scholar 

  19. Gellert C, Schottker B, Brenner H. Smoking and all-cause mortality in older people. Systematic review and meta-analysis. Arch Intern Med. 2012;172:837–44.

    Article  PubMed  Google Scholar 

  20. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009;41:1510–30.

    Article  PubMed  Google Scholar 

  21. Dodson JA, Reid KJ, Gill TM, et al. Slow gait among older adults post-AMI and risk for hospital readmission. J Am Coll Cardiol. 2012;59(Suppl A):A470.

    Google Scholar 

  22. Afilalo J, Eisenberg MJ, Morin JF, et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol. 2010;56:1668–76.

    Article  PubMed  Google Scholar 

  23. Oreopoulos A, Kalantar-Zadeh K, Sharma AM, Fonarow GC. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med. 2009;25:643–59.

    Article  PubMed  Google Scholar 

  24. Elveback L, Lie JT. Continued high prevalence of coronary artery disease at autopsy in Olmstead County, Minnesota, 1950 to 1970. Circulation. 1984;70:345–9.

    Article  PubMed  CAS  Google Scholar 

  25. Gersh BJ, Kronmal RA, Frye RL, et al. Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 or older. A report from the Coronary Artery Surgery Study. Circulation. 1983;67:483–91.

    Article  PubMed  CAS  Google Scholar 

  26. Gharacholou SM, Becker RC. Hemostasis and thrombosis in older adults. J Thromb Thrombolysis. 2009;27:249–51.

    Article  PubMed  Google Scholar 

  27. Alexander KP, Newby LK, Cannon CP, et al. Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes. Circulation. 2007;115:2549–69.

    Article  PubMed  Google Scholar 

  28. Alexander KP, Newby LK, Armstrong PW, et al. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction. Circulation. 2007;115:2570–89.

    Article  PubMed  Google Scholar 

  29. Fleg JL, Gerstenblith G, Zonderman AB, et al. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation. 1990;81:428–36.

    Article  PubMed  CAS  Google Scholar 

  30. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. J Am Coll Cardiol. 2002;40:1531–40.

    Article  PubMed  Google Scholar 

  31. Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. J Am Coll Cardiol. 2007;49:378–402.

    Article  PubMed  Google Scholar 

  32. Vliegenthart R, Oudkerk M, Hofman A, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112:572–7.

    Article  PubMed  Google Scholar 

  33. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;II:349–60.

    Google Scholar 

  34. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.

    Article  Google Scholar 

  35. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndrome. N Engl J Med. 2007;357:2001–15.

    Article  PubMed  CAS  Google Scholar 

  36. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57.

    Article  PubMed  CAS  Google Scholar 

  37. The PURSUIT Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436–43.

    Google Scholar 

  38. Krumholz HM, Hennen J, Ridker PM, et al. Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly. J Am Coll Cardiol. 1998;31:973–9.

    Article  PubMed  CAS  Google Scholar 

  39. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337:447–52.

    Article  PubMed  CAS  Google Scholar 

  40. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–30.

    Article  PubMed  CAS  Google Scholar 

  41. Jolly SS, Faxon DP, Fox KA, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. J Am Coll Cardiol. 2009;54:468–76.

    Article  PubMed  CAS  Google Scholar 

  42. Joyner CD, Peters RJ, Afzal R, et al. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Am Heart J. 2009;157:502–8.

    Article  PubMed  CAS  Google Scholar 

  43. McKellar SH, Brown ML, Frye RL, Schaff HV, Sundt TM. Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis. Nat Clin Prac Cardiovasc Med. 2008;5:738–46.

    Article  Google Scholar 

  44. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2008;52:e1–142.

    Article  PubMed  Google Scholar 

  45. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  PubMed  CAS  Google Scholar 

  46. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  PubMed  CAS  Google Scholar 

  47. Rudolph V, Knap M, Franzen O, et al. Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol. 2011;58:2190–5.

    Article  PubMed  Google Scholar 

  48. Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168:2095–103.

    Article  PubMed  Google Scholar 

  49. Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239–47.

    Article  PubMed  CAS  Google Scholar 

  50. Fleg JL, Morrell CH, Box AG, et al. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation. 2005;112:674–82.

    Article  PubMed  Google Scholar 

  51. Jugdutt BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010;15:401–5.

    Article  PubMed  Google Scholar 

  52. Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci. 2001;56:M88–96.

    Article  PubMed  CAS  Google Scholar 

  53. Harkness K, Demers C, Heckman GA, McKelvie RS. Screening for cognitive deficits using the Montreal cognitive assessment tool in outpatients ≥ 65 years of age with heart failure. Am J Cardiol. 2011;107:1203–7.

    Article  PubMed  Google Scholar 

  54. Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. Am J Cardiol. 2001;87:413–9.

    Article  PubMed  CAS  Google Scholar 

  55. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett Jr JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–82.

    Article  PubMed  CAS  Google Scholar 

  56. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol. 2009;53:e1–90.

    Article  PubMed  Google Scholar 

  57. Savage PA, Shaw AO, Miller MS, et al. Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc. 2011;43:1379–86.

    Article  PubMed  Google Scholar 

  58. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail. 2005;7:1133–44.

    Article  PubMed  Google Scholar 

  59. Rich MW. Device therapy in the elderly heart failure patient: what is the evidence? Expert Rev Cardiovasc Ther. 2010;8:1203–5.

    Article  PubMed  Google Scholar 

  60. Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Clinical response of cardiac resynchronization therapy in the elderly. Am Heart J. 2008;155:746–51.

    Article  PubMed  Google Scholar 

  61. Vitale CA, Chandekar R, Rodgers PE, Pagani FD, Malani PN. A call for guidance in the use of left ventricular assist devices in older adults. J Am Geriatr Soc. 2012;60:145–50.

    Article  PubMed  Google Scholar 

  62. Epstein AE, DiMarco JP, Ellengoben KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51:e1–62.

    Article  PubMed  Google Scholar 

  63. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat. 2006;13(162):1–209.

    Google Scholar 

  64. Dretzke J, Toff WE, Lip GY, Raftery J, Fry-Smith A, Taylor R. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev. 2004;2, CD003710.

    PubMed  Google Scholar 

  65. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.

    Article  PubMed  CAS  Google Scholar 

  66. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.

    Article  PubMed  CAS  Google Scholar 

  67. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–70.

    Article  PubMed  CAS  Google Scholar 

  68. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010;123:484–8.

    Article  PubMed  Google Scholar 

  69. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2011;57:e101–98.

    Article  PubMed  Google Scholar 

  70. Piccini JP, Hernandez AF, Zhao X, et al. Quality of care for atrial fibrillation among patients hospitalized for heart failure. J Am Coll Cardiol. 2009;54:1280–9.

    Article  PubMed  CAS  Google Scholar 

  71. McCormick D, Gurwitz JH, Goldberg RJ, et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med. 2001;161:2458–63.

    Article  PubMed  CAS  Google Scholar 

  72. Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother. 2008;42:523–32.

    Article  PubMed  CAS  Google Scholar 

  73. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.

    Article  PubMed  CAS  Google Scholar 

  74. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.

    Article  PubMed  CAS  Google Scholar 

  75. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.

    Article  PubMed  CAS  Google Scholar 

  76. Harper P, Young L, Merriman E. Bleeding risk with dabigatran in the frail elderly. N Engl J Med. 2012;366:864–6.

    Article  PubMed  CAS  Google Scholar 

  77. Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12.

    Article  PubMed  CAS  Google Scholar 

  78. Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066–78.

    Article  PubMed  Google Scholar 

  79. DeDenus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med. 2005;165:258–62.

    Article  Google Scholar 

  80. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363–73.

    Article  PubMed  Google Scholar 

  81. Yamada T, Kay GN. Catheter ablation of atrial fibrillation in the elderly. Pacing Clin Electrophysiol. 2009;32:1085–91.

    Article  PubMed  Google Scholar 

  82. Lee AM, Melby SJ, Damiano Jr RJ. The surgical treatment of atrial fibrillation. Surg Clin North Am. 2009;89:1001–20.

    Article  PubMed  Google Scholar 

  83. Hofmann JC, Wenger NS, Davis RB, et al. Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to understand prognoses and preference for outcomes and risks of treatment. Ann Intern Med. 1997;127:1–12.

    Article  PubMed  CAS  Google Scholar 

  84. Lampert R, Hayes DL, Annas GJ, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7:1008–26.

    Article  PubMed  Google Scholar 

  85. Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54:386–96.

    Article  PubMed  Google Scholar 

  86. Fleg JL, Bos AG, Brant LH, O’Connor FC. Longitudinal decline of aerobic capacity accelerates with age. Circulation. 2000;102(Suppl II):II-602.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine/Cardiology, Washington University, 660 S. Euclid Ave, 8086, St. Louis, MO, 63110, USA

    Michael W. Rich MD

Authors
  1. Michael W. Rich MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael W. Rich MD .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Department of Medicine,, Stony Brook University, School of Medicine,, Stony Brook, USA

    Kathleen Stergiopoulos

  2. Division of Cardiology, Stony Brook University, Stony Brook, New York, USA

    David L. Brown

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Rich, M.W. (2014). Cardiovascular Problems in the Elderly. In: Stergiopoulos, K., Brown, D. (eds) Evidence-Based Cardiology Consult. Springer, London. https://doi.org/10.1007/978-1-4471-4441-0_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4441-0_19

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4440-3

  • Online ISBN: 978-1-4471-4441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation